{"entity":{"type":"insider","cik":"0001873253","url":"/insider/0001873253","json_url":"/insider/0001873253.json","name":"Delfini Lisa","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":10,"first":"2023-02-15","last":"2024-05-24","span_basis":"filed_date"},"name_variants":[{"name":"Delfini Lisa","source":"filing","n_filings":10,"first_seen":"2023-02-15","last_seen":"2024-05-24"}],"transactions":[{"id":2141872,"accession":"0000950170-24-064598","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-064598","line_url":"/filing/0000950170-24-064598#line-2","is_derivative":false,"issuer_cik":"0001563880","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001563880","owner_cik":"0001873253","owner_name":"Delfini Lisa","owner_display_name":"Delfini Lisa","owner_url":"/insider/0001873253","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4350.0,"shares_display":"4,350","price_per_share":2.6402,"price_display":"2.64","price_state":"stated","total_value":11484.87,"total_display":"11,484.87","total_whole":"11,485","shares_owned_after":53279.0,"shares_owned_after_display":"53,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-22","filed_date":"2024-05-24","scope":"insider"},{"id":8630660,"accession":"0001209191-23-052687","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-052687","line_url":"/filing/0001209191-23-052687#line-2","is_derivative":false,"issuer_cik":"0001563880","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001563880","owner_cik":"0001873253","owner_name":"Delfini Lisa","owner_display_name":"Delfini Lisa","owner_url":"/insider/0001873253","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":785.0,"shares_display":"785","price_per_share":2.02,"price_display":"2.02","price_state":"stated","total_value":1585.7,"total_display":"1,585.70","total_whole":"1,586","shares_owned_after":35901.0,"shares_owned_after_display":"35,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-11","filed_date":"2023-10-12","scope":"insider"},{"id":8078807,"accession":"0001209191-23-049252","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-049252","line_url":"/filing/0001209191-23-049252#line-2","is_derivative":false,"issuer_cik":"0001563880","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001563880","owner_cik":"0001873253","owner_name":"Delfini Lisa","owner_display_name":"Delfini Lisa","owner_url":"/insider/0001873253","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":711.0,"shares_display":"711","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":1564.2,"total_display":"1,564.20","total_whole":"1,564","shares_owned_after":34394.0,"shares_owned_after_display":"34,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-11","filed_date":"2023-09-13","scope":"insider"},{"id":8726647,"accession":"0001209191-23-045595","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-045595","line_url":"/filing/0001209191-23-045595#line-2","is_derivative":false,"issuer_cik":"0001563880","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001563880","owner_cik":"0001873253","owner_name":"Delfini Lisa","owner_display_name":"Delfini Lisa","owner_url":"/insider/0001873253","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":682.0,"shares_display":"682","price_per_share":2.36,"price_display":"2.36","price_state":"stated","total_value":1609.52,"total_display":"1,609.52","total_whole":"1,610","shares_owned_after":32814.0,"shares_owned_after_display":"32,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-14","scope":"insider"},{"id":8188994,"accession":"0001209191-23-042078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-042078","line_url":"/filing/0001209191-23-042078#line-2","is_derivative":false,"issuer_cik":"0001563880","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001563880","owner_cik":"0001873253","owner_name":"Delfini Lisa","owner_display_name":"Delfini Lisa","owner_url":"/insider/0001873253","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":687.0,"shares_display":"687","price_per_share":2.34,"price_display":"2.34","price_state":"stated","total_value":1607.58,"total_display":"1,607.58","total_whole":"1,608","shares_owned_after":31204.0,"shares_owned_after_display":"31,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-11","filed_date":"2023-07-12","scope":"insider"},{"id":7954176,"accession":"0001209191-23-037029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-037029","line_url":"/filing/0001209191-23-037029#line-2","is_derivative":false,"issuer_cik":"0001563880","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001563880","owner_cik":"0001873253","owner_name":"Delfini Lisa","owner_display_name":"Delfini Lisa","owner_url":"/insider/0001873253","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":610.0,"shares_display":"610","price_per_share":2.64,"price_display":"2.64","price_state":"stated","total_value":1610.4,"total_display":"1,610.40","total_whole":"1,610","shares_owned_after":29599.0,"shares_owned_after_display":"29,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-12","filed_date":"2023-06-14","scope":"insider"},{"id":8332769,"accession":"0001209191-23-029399","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-029399","line_url":"/filing/0001209191-23-029399#line-2","is_derivative":false,"issuer_cik":"0001563880","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001563880","owner_cik":"0001873253","owner_name":"Delfini Lisa","owner_display_name":"Delfini Lisa","owner_url":"/insider/0001873253","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":562.0,"shares_display":"562","price_per_share":2.89,"price_display":"2.89","price_state":"stated","total_value":1624.18,"total_display":"1,624.18","total_whole":"1,624","shares_owned_after":27918.0,"shares_owned_after_display":"27,918","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-11","filed_date":"2023-05-15","scope":"insider"},{"id":7968820,"accession":"0001209191-23-024115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-024115","line_url":"/filing/0001209191-23-024115#line-2","is_derivative":false,"issuer_cik":"0001563880","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001563880","owner_cik":"0001873253","owner_name":"Delfini Lisa","owner_display_name":"Delfini Lisa","owner_url":"/insider/0001873253","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":840.0,"shares_display":"840","price_per_share":1.839,"price_display":"1.84","price_state":"stated","total_value":1544.76,"total_display":"1,544.76","total_whole":"1,545","shares_owned_after":26189.0,"shares_owned_after_display":"26,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-11","filed_date":"2023-04-12","scope":"insider"},{"id":7918070,"accession":"0001209191-23-018875","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-018875","line_url":"/filing/0001209191-23-018875#line-2","is_derivative":false,"issuer_cik":"0001563880","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001563880","owner_cik":"0001873253","owner_name":"Delfini Lisa","owner_display_name":"Delfini Lisa","owner_url":"/insider/0001873253","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":892.0,"shares_display":"892","price_per_share":1.7532,"price_display":"1.75","price_state":"stated","total_value":1563.8544,"total_display":"1,563.85","total_whole":"1,564","shares_owned_after":24737.0,"shares_owned_after_display":"24,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-13","filed_date":"2023-03-15","scope":"insider"},{"id":8248382,"accession":"0001209191-23-009694","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-009694","line_url":"/filing/0001209191-23-009694#line-2","is_derivative":false,"issuer_cik":"0001563880","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001563880","owner_cik":"0001873253","owner_name":"Delfini Lisa","owner_display_name":"Delfini Lisa","owner_url":"/insider/0001873253","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8474.0,"shares_display":"8,474","price_per_share":2.45,"price_display":"2.45","price_state":"stated","total_value":20761.3,"total_display":"20,761.30","total_whole":"20,761","shares_owned_after":23338.0,"shares_owned_after_display":"23,338","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001563880","name":"Trevi Therapeutics, Inc.","url":"/issuer/0001563880","role":"Officer (Chief Financial Officer)","n_filings":10,"first_seen":"2023-02-15","last_seen":"2024-05-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001873253","retrieved_at":"2026-08-25T00:22:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}